IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Alnylam
Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against
Alnylam Pharmaceuticals, Inc. (“Alnylam” or “the Company”) (NASDAQ:
ALNY) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the
U.S. Securities and Exchange Commission.
Investors who purchased the Company's shares between February 15, 2018 and September 12, 2018, inclusive (the ''Class Period''),
are encouraged to contact the firm before November 26, 2018.
If you are a shareholder who suffered a loss,
click here to participate.
We also encourage you to contact Brian Schall, or Sherin Mahdavian, of the Schall Law Firm, 1880 Century Park East, Suite 404,
Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website
at www.schallfirm.com,
or by email at brian@schallfirm.com.
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If
you choose to take no action, you can remain an absent class member.
According to the Complaint, the Company made false and misleading statements to the market. Alnylam overstated the efficacy of
its Onpattro (patisiran) lipid complex injection, and also inflated the safety of the treatment. Based on these facts, the
Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth
about Alnylam, investors suffered damages.
Join the case to recover your losses.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder
rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of
ethics.
The Schall Law Firm
Brian Schall, Esq.,
Sherin Mahdavian, Esq.,
www.schallfirm.com
310-301-3335
info@schallfirm.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20181001006052/en/